12 latest hospital credit rating downgrades

The following 12 hospital and health system credit rating downgrades occurred between Oct. 1 and Nov. 30. They are listed below in alphabetical order:

Advertisement

1. Augusta (Ga.) University Health System — from “BBB” to “BBB-” (S&P Global Ratings); from “Baa1” to “Baa3” (Moody’s Investors Service)

2. Bibb County Medical Center (Centreville, Ala.) — from “BBB+” to “BB” (S&P Global Ratings)

3. Covenant Health (Tewksbury, Mass.) — from “BBB+” to “BBB” (Fitch Ratings)

4. Delta (Colo.) County Memorial Hospital — from “BB+” to “BB” (S&P Global Ratings)

5. Mercy Medical Center (Des Moines, Iowa) — from “A” to “A-” (S&P Global Ratings)

6. OSF HealthCare (Peoria, Ill.) — from “A2” to “A3” (Moody’s Investors Service)

7. Parmer County (Texas) Hospital District — from “Baa1” to “Baa2” (Moody’s Investors Service)

8. Princeton (W.Va.) Community Hospital — from “BBB+” to “BBB” (S&P Global Ratings)

9. ProMedica Health System (Toledo, Ohio) — from “Baa1” to “Baa3” (Moody’s Investors Service); from “BBB+” to “BBB” (Fitch Ratings)

10. Sparrow Health System (Lansing, Mich.) — from “A1” to “A2” (Moody’s Investors Service)

11. St. John’s Riverside Hospital (Yonkers, N.Y.) — from “B-” to “CCC+” (S&P Global Ratings)

12. Tower Health (West Reading, Pa.) — from “A3” to “Baa2” (Moody’s Investors Service)

More articles on healthcare finance:

Cleveland Clinic’s operating income up 65% in Q3
Texas health system closes hospital, lays off 972
CHS absorbs $47M of patient debts in settlement

 

 

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Financial Management

Advertisement

Comments are closed.